Major Korean companies are ramping up their investments in Indonesia, which they regard as a base for advancing into Southeast Asia. Korean companies' investments are made in diverse sectors, including electric vehicles, batteries, petrochemicals, and biotechnology. The Indonesian government is
The authors are analysts of Shinhan Investment Corp. They can be reached at shawn1225@shinhan.com and sehunjang@shinhan.com, respectively. – Ed. Biotech stocks on a losing streak since 2021Biotech stocks have continued on a losing streak in 1H22. Investor appetite for growth stocks has declined in t
South Korean Trade, Industry and Energy Minister Lee Chang-yang had a meeting in Seoul on June 8 with UAE Minister of Industry and Advanced Technology and Abu Dhabi National Oil Co. CEO Sultan Ahmed Al Jaber.At the meeting, they discussed industrial and technological cooperation and cooperation in e
LG Group will invest a total of 106 trillion won in Korea by 2026 to strengthen its capabilities in future growth areas, including batteries, next-generation displays and biotechnology. It aims to build a high-tech, high-value-added production and R&D core base in Korea.The group announced a mid- to
Major conglomerates, including the top 10 business groups, have come up with plans to invest more than 1,000 trillion won over the next five years in response to the new administration's business-friendly stance.Unlike the previous administration, which held back corporations through bulky regul
Pfizer has filed a patent infringement lawsuit against Samsung Bioepis with the Australian Federal Court to suspend sales of the latter's SB4, a biosimilar of Enbrel, which is an autoimmune disease treatment sold by Pfizer.This is the first time that Pfizer has filed a lawsuit against a Korean b
MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 14 that it has entered into a clinical trial agreement with University Hospitals Cleveland Medical Center in the United States to pursue an investigator-initiated clinical trial in patients with
MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 11 that it has partnered with HITS, an artificial intelligence (AI) drug discovery company, to co-develop new drugs.Under the terms of the agreement, the two companies will practice drug develop
A research team led by Jo Hyun-su at the Korea Research Institute of Bioscience and Biotechnology discovered that a substance from intestinal microorganisms kills colon cancer cells. According to the team, the discovery is expected to make a great contribution to microbiome-based colon cancer cure d
Yeonsu-gu of Incheon hosted the 5th International Conference on Learning Cities (ICLC) at the Songdo Conventia from Oct. 27-30, with some 2,000 representatives and officials from 229 member cities of 64 countries attending.While the world's biggest lifelong learning festival ended about two mont
SK Bioscience announced on Dec. 24 that it has signed a contract manufacturing organization (CMO) and licensing deal with Novavax for the production and global supply of the U.S. biotechnology company's COVID-19 vaccine NVX-CoV2373. The contract will run until December next year.Under the contra
The Ministry of Trade, Industry and Energy and the Korea Biotechnology Industry Organization announced that exports from the biotech industry of South Korea increased 53.1 percent to 10.0158 trillion won last year and imports in the industry increased 13.4 percent to 2.3424 trillion won in that peri
Moderna's COVID-19 vaccines produced by Samsung Biologics have obtained approval from the Korean Ministry of Food and Drug Safety. This means that the vaccines can be sold at home and abroad.The approved product is Spikevax, which is administered in the form of an injection. It is the first dome
Samsung Electronics has recently launched a robot business team to promote commercialization of home robots in earnest. It plans to roll out products as soon as possible, and large-scale investments in related businesses are also expected.The company has recently upgraded a task force for robot comm
Samsung Group has decided to invest 240 trillion won over the three years from 2021, 180 trillion won at home and 60 trillion won overseas. Of the 60 trillion won set aside for overseas, 20 trillion won will be used to build a new foundry in Taylor, Texas of the United States.Samsung plans to invest
Samsung Biologics has forged a partnership with GreenLight Biosciences, a U.S. biotechnology company, to manufacture the latter's messenger RNA COVID-19 vaccine candidate at commercial scale.GreenLight Biosciences is dedicated to making ribonucleic acid (RNA) products affordable and accessible f
The author is an analyst of KB Securities. She can be reached at leesunhwa@kbfg.com. -- Ed. Maintain BUY, target price of KRW620,000 We maintain BUY and TP of KRW620,000 on CJCJ. The processed food business has been gaining overseas market share while benefiting from domestic price hikes, and Bio ha
South Korean President Moon Jae-in attended the V4-Korea Business Forum in Budapest on Nov. 3 during his state visit to Hungary from Nov. 2 to 4. There, South Korea and the four countries, that is, Hungary, Poland, Slovakia and the Czech Republic signed seven MOUs for more collaboration in various f
Cerecin Inc., a clinical-stage biotechnology company pioneering innovative neurotherapeutics, announced on Oct. 19 that it has raised US$40 million in an oversubscribed round of financing. A Series II investment was initially made by long-term investor, Nestle. In follow up to this round, Series IIA
Hanwha Solutions announced in August that it would acquire renewable energy developer RES France for approximately one trillion won. “The French company was expected to be acquired by a European company, but Hanwha Solutions surprised the entire industry,” said an industry source, adding, “The South